Misa Ariyoshi

Pexidartinib and Immune Checkpoint Inhibitors Combine to Activate Tumor Immunity in a Murine Colorectal Cancer Model by Depleting M2 Macrophages Differentiated by Cancer-Associated Fibroblasts

Daisuke Shimizu, Ryo Yuge, Yuki Kitadai et al. · International Journal of Molecular Sciences · 2024 · 23 citations · Full text

Medicine, Immunology, Oncology +17

The Anti-Tumor Effect of the Newly Developed LAT1 Inhibitor JPH203 in Colorectal Carcinoma, According to a Comprehensive Analysis

Rina Otani, Hidehiko Takigawa, Ryo Yuge et al. · Cancers · 2023 · 16 citations · Full text

Medicine, Oncology, Pharmacology +11

Anti-tumor necrosis factor-alpha monoclonal antibody suppresses colorectal cancer growth in an orthotopic transplant mouse model

Takeshi Takasago, Ryohei Hayashi, Yoshitaka Ueno et al. · PLoS ONE · 2023 · 10 citations · Full text

Medicine, Immunology, Oncology +17

Analysis of anti-tumor effect and mechanism of GLS1 inhibitor CB-839 in colorectal cancer using a stroma-abundant tumor model

Ryo Miyamoto, Hidehiko Takigawa, Ryo Yuge et al. · Experimental and Molecular Pathology · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +15

WEE1 Inhibitor Adavosertib Exerts Antitumor Effects on Colorectal Cancer, Especially in Cases with p53 Mutations

Misa Ariyoshi, Ryo Yuge, Yuki Kitadai et al. · Cancers · 2024 · 10 citations · Full text

Medicine, Oncology, Pharmacology +17